Average one-year price target for Microbot Medical (NasdaqCM: MBOT) was raised to $7.65/share, a 12.50% increase from the prior $6.80 target dated Feb 21, 2026. The $7.65 figure is the mean of analyst targets. This is a modestly positive signal for the stock but is unlikely to move broader markets beyond potential single-stock re-rating.
Average one-year price target for Microbot Medical (NasdaqCM: MBOT) was raised to $7.65/share, a 12.50% increase from the prior $6.80 target dated Feb 21, 2026. The $7.65 figure is the mean of analyst targets. This is a modestly positive signal for the stock but is unlikely to move broader markets beyond potential single-stock re-rating.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
